Home LiteratureArticle Details
PMID: 9605154 Published · ppublish English Journal Article Research Support, Non-U.S. Gov't Research Support, U.S. Gov't, P.H.S.

Control of Leishmania major infection in mice lacking TNF receptors.

Journal of immunology (Baltimore, Md. : 1950) ·Vol. 160 ·No. 11 ·1998-06-01 ·Pages 5506-13

Nashleanas M, Kanaly S, Scott P

Abstract

TNF participates in the induction of nitric oxide (NO) production and macrophage activation, leading to the elimination of intracellular pathogens. We previously found that TNF receptor p55-deficient mice (TNFRp55-/-) control replication of Leishmania major in vivo but fail to resolve their lesions. Here we report that mice lacking the p75 receptor (TNFRp75-/-) or both receptors (TNFRp55p75-/-), also control parasite replication, albeit mice lacking the p55 receptor (either TNFRp55-/- or TNFRp55p75-/-) are delayed in their elimination of L. major compared with controls. All TNF receptor-deficient mice developed a Thl-type immune response and up-regulated inducible NO synthase (iNOS) mRNA gene expression in lesions during infection. Thus, neither TNF receptor appears to be absolutely required for NO production or elimination of L. major in vivo. In vitro, however, while macrophages from naive TNFRp75-/- mice could be activated to produce NO and kill L. major, we observed a defect in NO production and parasite killing by resident peritoneal macrophages from naive TNFRp55-/- or TNFRp55p75-/- mice. However, when macrophages were elicited with leishmanial Ag from 4-wk-infected TNFRp55-/- or TNFRp55p75-/- mice, they produced NO and were leishmanicidal. These data suggest that the TNFRp75 plays no essential role in L. major infection in mice and that the p55 receptor may be required for optimal macrophage activation. However, the results also show that a mechanism exists by which macrophages can be primed in vivo during L. major infection to produce NO and kill L. major in the absence of signaling through either of the TNF receptors.

MeSH Terms
Animals Antigens, CD/genetics,metabolism Leishmania major/growth & development,immunology Leishmaniasis, Cutaneous/genetics,immunology,prevention & control Macrophage Activation/genetics Macrophages, Peritoneal/immunology,metabolism Mice Mice, Inbred C57BL Mice, Knockout Nitric Oxide Synthase/biosynthesis,genetics Nitric Oxide Synthase Type II RNA, Messenger/biosynthesis Receptors, Tumor Necrosis Factor/deficiency,genetics,metabolism Receptors, Tumor Necrosis Factor, Type I Receptors, Tumor Necrosis Factor, Type II Th1 Cells/immunology,metabolism Time Factors Up-Regulation/genetics,immunology
Chemicals
Antigens, CD RNA, Messenger Receptors, Tumor Necrosis Factor Receptors, Tumor Necrosis Factor, Type I Receptors, Tumor Necrosis Factor, Type II Nitric Oxide Synthase Nitric Oxide Synthase Type II Nos2 protein, mouse
Authors & Affiliations
3 authors, click to expand affiliations / ORCID
Nashleanas M
University of Pennsylvania School of Veterinary Medicine, Philadelphia 19104, USA.
Kanaly S
Scott P
Article Info
Journal
Journal of immunology (Baltimore, Md. : 1950)
Abbr.
J Immunol
ISSN
0022-1767
Published
1998-06-01
Pages
5506-13
Language
English
Region
United States
NLM ID
2985117R
Subset
IM
Grants
NIAID NIH HHS · AI 35914 · United States
NIAID NIH HHS · AI 41880 · United States
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: [email protected]